Strongbridge Biopharma Plc Announces Court Hearing Date To Approve Proposed Acquisition By Xeris Pharmaceuticals, Inc.
Acquiring Company
Xeris Biopharma Holdings
Acquired Company
Strongbridge Biopharma plc
ChicagoTrevoseBiotechnologyHealthcareHealth CareBiopharmaBiotechnologyHealthcareHealth CareScience And EngineeringDescription
Strongbridge Biopharma plc (NASDAQ: SBBP) (the “Company” or “Strongbridge”) today announced that the High Court of Ireland (the “Court”) has set the date of the final court hearing to sanction the proposed acquisition of Strongbridge by Xeris Pharmaceuticals, Inc. (“Xeris”) by means of scheme of arrangement (the “Scheme”) under Chapter 1 of Part 9 of the Irish Companies Act 2014 (the “Act”).
Quick answer
Xeris Biopharma Holdings is acquiring Strongbridge Biopharma plc, announced September 23, 2021. Xeris Biopharma Holdings is based in Chicago, Illinois, United States.
- How much did Xeris Biopharma Holdings pay for Strongbridge Biopharma plc?
- The deal value was not disclosed.
- What does Xeris Biopharma Holdings do?
- Xeris Biopharma Holdings, Inc. is a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies.
- Where are Xeris Biopharma Holdings and Strongbridge Biopharma plc based?
- Xeris Biopharma Holdings is based in Chicago, Illinois, United States. Strongbridge Biopharma plc is based in Trevose, Pennsylvania, United States.
Source: Fundz verified event record.
Other recent acquisitions in Healthcare and Biopharma
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Strongbridge Biopharma Plc Announces Shareholder Approval Of Proposed Acquisition By Xeris Pharmaceuticals, Inc. (September 8, 2021)
- Enveric Biosciences Announces Closing Of Magicmed Industries Acquisition (September 18, 2021)
- Labcorp Completes Acquisition Of Myriad Autoimmune’S Vectra Testing Business (September 13, 2021)
- Labcorp Completes Acquisition Of Myriad Autoimmune’S Vectra Testing Business (September 13, 2021)
- 23Andme Announces The Closing Of Its Acquisition Of Lemonaid Health (November 1, 2021)
- Agomab Therapeutics To Acquire Origo Biopharma (October 28, 2021)
Who to call at Xeris Biopharma Holdings, and when
When Xeris Biopharma Holdings changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Xeris Biopharma Holdings raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Xeris Biopharma Holdings, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Xeris Biopharma Holdings. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Xeris Biopharma Holdings makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Strongbridge Biopharma plc?
Strongbridge Biopharma plc was acquired by Xeris Biopharma Holdings, based in Chicago. The deal was reported on September 23, 2021. Xeris Biopharma Holdings, Inc. is a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies. Xeris Biopharma Holdings is publicly traded (XERS) and operates in Biotechnology.
When did Xeris Biopharma Holdings acquire Strongbridge Biopharma plc?
Xeris Biopharma Holdings's acquisition of Strongbridge Biopharma plc was reported on September 23, 2021. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Strongbridge Biopharma plc do?
Strongbridge Biopharma plc is a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs. It is privately held, operating in Biotechnology, and is based in Trevose.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.